Cargando…
Kuhuang injection exerts a protective effect by activating PPAR-γ in an in vitro model of chlorpromazine-induced cholestatic liver injury constructed by tissue engineering
CONTEXT: Kuhuang (KH) injection is a widely used anticholestatic drug in the clinic and the mechanisms are still unclear. OBJECTIVE: This study uses a new 3D tissue-engineered (TE) liver platform to study the ability of kuhuang to ameliorate liver injury induced by chlorpromazine (CPZ) and the possi...
Autores principales: | Wu, Qiao, Duan, Zhongping, Huang, Long, Li, Zhijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467616/ https://www.ncbi.nlm.nih.gov/pubmed/36063125 http://dx.doi.org/10.1080/13880209.2022.2110128 |
Ejemplares similares
-
PPARα activation protects against cholestatic liver injury
por: Zhao, Qi, et al.
Publicado: (2017) -
Kuhuang alleviates liver fibrosis by modulating gut microbiota-mediated hepatic IFN signaling and bile acid synthesis
por: Shen, Bo, et al.
Publicado: (2022) -
Suspected systemic uptake of chlorpromazine after retrobulbar injection
por: Cosgrove, Ryan, et al.
Publicado: (2020) -
ECT-CHLORPROMAZINE COMBINATION COMPARED WITH CHLORPROMAZINE ONLY IN SCHIZOPHRENIA1
por: Janakiramaiah, N., et al.
Publicado: (1981) -
Chlorpromazine-induced perturbations of bile acids and free fatty acids in cholestatic liver injury prevented by the Chinese herbal compound Yin-Chen-Hao-Tang
por: Yang, Qiaoling, et al.
Publicado: (2015)